Search Results - "Lai, Hengli"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Promoting role of circ-Jarid2/miR-129-5p/Celf1 axis in cardiac hypertrophy by Fang, Yan, Tao, Yu, Zhou, Haiwen, Lai, Hengli

    Published in Gene therapy (01-12-2021)
    “…Cardiac hypertrophy is imposed much pressure on heart and threatening our live. Previous study suggested that dysregulation of Celf1 is largely connecting to…”
    Get full text
    Journal Article
  2. 2

    Effect of low-dose rivaroxaban on bleeding events in low-weight patients with nonvalvular atrial fibrillation: a retrospective propensity score-matched cohort study by Liu, Yuan, Lai, Hengli, Chen, Zhenhuan, Xiong, Ganwei

    Published in Frontiers in cardiovascular medicine (13-11-2024)
    “…Objective To investigate the effect of low-dose rivaroxaban on bleeding events in low-weight patients with nonvalvular atrial fibrillation. Methods A…”
    Get full text
    Journal Article
  3. 3

    Thioredoxin Reductase 2 Synergizes with Cytochrome c, Somatic to Alleviate Doxorubicin-Induced Oxidative Stress in Cardiomyocytes and Mouse Myocardium by Li, Chuyun, Lai, Hengli, Cai, Xinyong, Liu, Yuanyuan, Hong, Lang, Huang, Xiao, Shao, Liang

    Published in International Heart Journal (31-03-2023)
    “…Doxorubicin (DOX) may cause multiple side effects, which include cardiotoxicity. Hence, to ascertain the impact of thioredoxin reductase 2 (TXNRD2) and…”
    Get full text
    Journal Article
  4. 4

    Relationship between Serum miR-106 and MYL4 Levels and the Prevalence, Risk Stratification, and Prognosis of Atrial Fibrillation by Liu, Yanfeng, Zhou, Haiwen, Tao, Yu, Xu, Zhicheng, Lai, Hengli

    Published in Journal of immunology research (14-07-2022)
    “…Objective. To analyze the predictive value of serum microRNA-106 (miRNA-106), miR-106, and myosin light chain 4 (MYL4) levels on the prevalence of atrial…”
    Get full text
    Journal Article
  5. 5

    Salmonella pathogenicity island 1 knockdown confers protection against myocardial fibrosis and inflammation in uremic cardiomyopathy via down-regulation of S100 Calcium Binding Protein A8/A9 transcription by Cai, Xinyong, Hong, Lang, Liu, Yuanyuan, Huang, Xiao, Lai, Hengli, Shao, Liang

    Published in Renal failure (31-12-2022)
    “…Uremic cardiomyopathy (UCM) is a characteristic cardiac pathology that is commonly found in patients with chronic kidney disease. This study dissected the…”
    Get full text
    Journal Article
  6. 6

    Downregulation of MicroRNA-29-3p Following Percutaneous Coronary Intervention: An Implication of YY1/IRAK1 Pathway in the Post-Vascular Injury Inflammation by Zhou, Yunying, Yang, Yong, Hong, Lang, Shao, Liang, Lai, Hengli, Zhu, Fangxin, Lan, Jianyun

    Published in Acta Cardiologica Sinica (01-09-2023)
    “…This study explored the expression of microRNA (miR)-29b-3p following percutaneous coronary intervention (PCI) and the implication of its downstream Yin Yang 1…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Successful treatment of atrial flutter post-radiofrequency ablation for atrial fibrillation following atrial septal defect occlusion: a case report of pulsed field ablation by Hu, Jing, Ding, Ligang, Gunawan, Evan, Lai, Hengli, Yao, Yan

    Published in European heart journal : case reports (01-11-2024)
    “…Abstract Background Atrial flutter (AFL) is a common arrhythmia following radiofrequency ablation (RFA) for atrial fibrillation (AF), with varying incidence…”
    Get full text
    Journal Article
  9. 9

    SIRT4 suppresses the PI3K/Akt/NF‑κB signaling pathway and attenuates HUVEC injury induced by oxLDL by Tao, Yu, Yu, Songping, Chao, Min, Wang, Yang, Xiong, Jianhua, Lai, Hengli

    Published in Molecular medicine reports (01-06-2019)
    “…Atherosclerosis is a chronic and progressive disease. Its morbidity and mortality rates have demonstrated an increase in recent years. The present study aimed…”
    Get full text
    Journal Article
  10. 10

    JinJiang ablation catheter is no inferior than Johnson ablation catheter in radiofrequency ablation of paroxysmal supraventricular tachycardia by Li, Ying, Xiong, Ganwei, Liu, Yuan, Huang, Xiantao, Liu, Yanfeng, Zhou, Haiwen, Xu, Zhicheng, Tao, Yu, Zhang, Fanzhi, Lai, Hengli, Chen, Zhenhuan

    Published in Pacing and clinical electrophysiology (01-02-2024)
    “…Background Paroxysmal supraventricular tachycardia (PSVT) is characterized by episodes of rapid tachycardia with sudden onset and sudden termination. PSVT…”
    Get full text
    Journal Article
  11. 11

    Thioredoxin Reductase 2 Synergizes with Cytochrome c, Somatic to Alleviate Doxorubicin-Induced Oxidative Stress in Cardiomyocytes and Mouse Myocardium by Li, Chuyun, Lai, Hengli, Cai, Xinyong, Liu, Yuanyuan, Hong, Lang, Huang, Xiao, Shao, Liang

    Published in International Heart Journal (2023)
    “…Doxorubicin (DOX) may cause multiple side effects, which include cardiotoxicity. Hence, to ascertain the impact of thioredoxin reductase 2 (TXNRD2) and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    SIRT4 suppresses the PI3K/Akt/NF-[kappa]B signaling pathway and attenuates HUVEC injury induced by oxLDL by Tao, Yu, Yu, Songping, Chao, Min, Wang, Yang, Xiong, Jianhua, Lai, Hengli

    Published in Molecular medicine reports (01-06-2019)
    “…Atherosclerosis is a chronic and progressive disease. Its morbidity and mortality rates have demonstrated an increase in recent years. The present study aimed…”
    Get full text
    Journal Article
  14. 14
  15. 15